Cat.#: ACPP-1168
| Despition | KCNJ5 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1406 | Human Recoverin Protein (AC1406) | 10 µg | inquiry |
| ACPP-1682 | Human CALB1 Protein (AC1682) | 10 µg | inquiry |
| ACPP-1381 | Human DTNBP1 Protein (AC1381) | 5 µg | inquiry |
| ACPP-1265 | EDG8 Blocking Peptide (AC1265) | 250 µg | inquiry |
| ACPP-1357 | P2Y12 Blocking Peptide (AC1357) | 250 µg | inquiry |
| ACPP-1400 | ACTH (AC1400) | 2 mg | inquiry |
| ACPP-1578 | Human QPCT Protein (AC1578) | 2 µg | inquiry |
| ACPP-1626 | Human SHC1 Protein (AC1626) | 5 µg | inquiry |
| ACPP-1405 | Human Ciliary Neurotrophic Factor (Active) Protein (AC1405) | 100 µg | inquiry |
| ACPP-1822 | Human CHGA Protein, GST (AC1822) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.